Document Detail


Identification and characterization of the first mutation (Arg776Cys) in the C-terminal domain of the Human Molybdenum Cofactor Sulfurase (HMCS) associated with type II classical xanthinuria.
MedLine Citation:
PMID:  17368066     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Classical xanthinuria type II is an autosomal recessive disorder characterized by deficiency of xanthine dehydrogenase and aldehyde oxidase activities due to lack of a common sulfido-olybdenum cofactor (MoCo). Two mutations, both in the N-terminal domain of the Human Molybdenum Cofactor Sulfurase (HMCS), were reported in patients with type II xanthinuria. Whereas the N-terminal domain of HMCS was demonstrated to have cysteine desulfurase activity, the C-terminal domain hypothetically transfers the sulfur to the MoCo. We describe the first mutation in the C-terminal domain of HMCS identified in a Bedouin-Arab child presenting with urolithiasis and in an asymptomatic Jewish female. Patients were diagnosed with type II xanthinuria by homozygosity mapping and/or allopurinol loading test. The Bedouin-Arab child was homozygous for a c.2326C>T (p.Arg776Cys) mutation, while the female patient was compound heterozygous for this and a novel c.1034insA (p.Gln347fsStop379) mutation in the N-terminal domain of HMCS. Cosegregation of the homozygous mutant genotype with hypouricemia and hypouricosuria was demonstrated in the Bedouin family. Haplotype analysis indicated that p.Arg776Cys is a recurrent mutation. Arg776 together with six surrounding amino acid residues were found fully conserved and predicted to be buried in homologous eukaryotic MoCo sulfurases. Moreover, Arg776 is conserved in a diversity of eukaryotic and prokaryotic proteins that posses a domain homologous to the C-terminal domain of HMCS. Our findings suggest that Arg776 is essential for a core structure of the C-terminal domain of the HMCS and identification of a mutation at this site may contribute clarifying the mechanism of MoCo sulfuration.
Authors:
Hava Peretz; Meirav Shtauber Naamati; David Levartovsky; Ayala Lagziel; Esther Shani; Ivona Horn; Hanna Shalev; Daniel Landau
Related Documents :
14978696 - Association of glucose-6-phosphate dehydrogenase deficiency and x-linked chronic granul...
17113806 - Mutation and biochemical analysis of 19 probands with mut0 and 13 with mut- methylmalon...
6517516 - Distribution of glucose-6-phosphate dehydrogenase phenotypes in five east asian populat...
15132136 - Dihydropyrimidine dehydrogenase pharmacogenetics in the taiwanese population.
18602826 - Exclusion of biglycan mutations in a cohort of patients with neuromuscular disorders.
12764196 - The birth of an alternatively spliced exon: 3' splice-site selection in alu exons.
Publication Detail:
Type:  Journal Article     Date:  2007-03-23
Journal Detail:
Title:  Molecular genetics and metabolism     Volume:  91     ISSN:  1096-7192     ISO Abbreviation:  Mol. Genet. Metab.     Publication Date:  2007 May 
Date Detail:
Created Date:  2007-04-13     Completed Date:  2007-07-25     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  9805456     Medline TA:  Mol Genet Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  23-9     Citation Subset:  IM    
Affiliation:
Clinical Biochemistry Laboratory, Sourasky Medical Center, Tel Aviv, Israel. hperetz@tasmc.health.gov.il
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aldehyde Oxidase / deficiency*,  genetics,  metabolism
Allopurinol / metabolism
Amino Acid Sequence
Amino Acid Substitution*
Arginine / genetics
Base Sequence
Coenzymes / metabolism
Cysteine / genetics
Female
Homozygote
Humans
Infant, Newborn
Male
Metalloproteins / metabolism
Mutation
Pedigree
Phylogeny
Protein Structure, Tertiary
Pteridines / metabolism
Sequence Alignment
Sulfurtransferases / chemistry,  genetics*,  metabolism
Xanthine Dehydrogenase / deficiency*,  genetics,  metabolism
Xanthines / blood,  urine*
Chemical
Reg. No./Substance:
0/Coenzymes; 0/Metalloproteins; 0/Pteridines; 0/Xanthines; 315-30-0/Allopurinol; 52-90-4/Cysteine; 73508-07-3/molybdenum cofactor; 74-79-3/Arginine; EC 1.17.1.4/Xanthine Dehydrogenase; EC 1.2.3.1/Aldehyde Oxidase; EC 2.8.1.-/MOCOS protein, human; EC 2.8.1.-/Sulfurtransferases

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
Next Document:  Outer membrane protein A of Escherichia coli K1 selectively enhances the expression of intercellular...